Loading...
RaySearch Laboratories AB (publ)
RSLBF•PNK
HealthcareMedical - Healthcare Information Services
$32.19
$0.00(0.00%)
RaySearch Laboratories AB (publ) (RSLBF) Financial Performance & Statements
Review RaySearch Laboratories AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
16.62%
↑ 16.62%
Operating Income Growth
126.75%
↑ 126.75%
Net Income Growth
149.49%
↑ 149.49%
Operating Cash Flow Growth
6.43%
↑ 6.43%
Operating Margin
22.86%
↑ 22.86%
Gross Margin
91.88%
↑ 91.88%
Net Profit Margin
17.66%
↑ 17.66%
ROE
26.48%
↑ 26.48%
ROIC
20.46%
↑ 20.46%
RaySearch Laboratories AB (publ) (RSLBF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for RaySearch Laboratories AB (publ) stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $322.67M | $293.30M | $318.87M | $257.20M |
| Cost of Revenue | $24.79M | $27.86M | $23.74M | $96.20M |
| Gross Profit | $297.87M | $265.45M | $295.12M | $160.99M |
| Gross Profit Ratio | $0.92 | $0.91 | $0.93 | $0.63 |
| R&D Expenses | $71.29M | $68.52M | $68.39M | $61.18M |
| SG&A Expenses | $163.68M | $134.27M | $146.73M | $58.39M |
| Operating Expenses | $224.29M | $203.62M | $215.80M | $119.57M |
| Total Costs & Expenses | $249.09M | $231.48M | $239.54M | $215.77M |
| Interest Income | $0.00 | $0.00 | $2.17M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $155000.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $27.90M | $73.10M |
| EBITDA | $73.58M | $61.83M | $79.32M | $73.67M |
| EBITDA Ratio | $0.23 | $0.21 | $0.25 | $0.29 |
| Operating Income | $73.58M | $61.83M | $79.32M | $41.42M |
| Operating Income Ratio | $0.23 | $0.21 | $0.25 | $0.16 |
| Other Income/Expenses (Net) | $3.86M | -$3.50M | $2.17M | $4.19M |
| Income Before Tax | $77.44M | $58.33M | $81.49M | $45.61M |
| Income Before Tax Ratio | $0.24 | $0.20 | $0.26 | $0.18 |
| Income Tax Expense | $17.44M | $12.94M | $20.06M | $8.91M |
| Net Income | $60.00M | $45.39M | $61.43M | $36.70M |
| Net Income Ratio | $0.19 | $0.15 | $0.19 | $0.14 |
| EPS | $1.75 | $1.32 | $1.79 | $1.07 |
| Diluted EPS | $1.75 | $1.32 | $1.79 | $1.07 |
| Weighted Avg Shares Outstanding | $34.28M | $34.28M | $34.32M | $34.28M |
| Weighted Avg Shares Outstanding (Diluted) | $34.28M | $34.28M | $34.32M | $34.28M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan